Objective This study investigates the relationship between programmed death ligand-1 (PD-L1), anaplastic lymphoma kinase (ALK), and c-ros oncogene 1 (ROS1) expression in lung adenocarcinoma (ADC). The gene discussed is ALK; the disease is lung adenocarcinoma.